CA-125 as a response marker for vintafolide plus pegylated liposomal doxorubicin (PLO) vs PLO alone in platinum-resistant ovarian cancer: The PRECEDENT trial [1]
Title: CA-125 as a response marker for vintafolide plus pegylated liposomal doxorubicin (PLO) vs PLO alone in platinum-resistant ovarian cancer: The PRECEDENT trial
Author(s): Naumann, R.; Bidzinski, M.; Lovejoy, C.; et al.
Source: European Journal of Cancer Volume: 49 Pages: S730 Published: 2013
Times Cited: 0
Nauka [2]